EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Left atrial appendage occlusion in patients with end-stage renal disease: an individual patient-level meta-analysis

Juan F Rodriguez-Riascos iD, Hema S Vemulapalli iD, Ibrahim Akin iD, Luis A Areiza iD, Domenico G Della Rocca iD, Ingo Eitel iD, Thomas Fink iD, Simonetta Genovesi iD, Joelle Kefer iD, David Zweiker iD, Poojan Prajapati iD, Komandoor Srivathsan iD

Europace · 07.10.2025 · 27 (10)

DOI: 10.1093/europace/euaf198 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Europace, online erschienen am 29.08.2025. Verfasst von Juan F Rodriguez-Riascos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Diseases, Mayo Clinic, 5777 East Mayo Boulevard, Phoenix, AZ 85054, USA. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Kidney Failure, Chronic, Thromboembolism. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Mayo Clinic Arizona Cardiovascular Clinical Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Patients with end-stage renal disease (ESRD) and atrial fibrillation present a challenge for thromboembolic prevention, given their elevated risks of both thromboembolism and bleeding. Anticoagulants carry a higher bleeding risk in this population without clear evidence of thromboembolic benefit. This study aims to define the role of left atrial appendage occlusion (LAAO) as a preventive strategy for patients with ESRD. Methods and results A systematic literature review was conducted to identify studies reporting outcomes in patients with ESRD who underwent LAAO. Meta-analyses of aggregate and individual patient data were performed to evaluate acute and long-term outcomes and compare them with those of patients without ESRD. Seventeen studies reporting data from 24 127 patients, including 1047 with ESRD, were included. Procedural complications were more common in patients with ESRD (RR 2.23; P = 0.02), with a pooled rate of 4% (95% CI, 1–9%). There was no significant difference in thromboembolic event rates during follow-up between the groups (IRR 1.44; P = 0.16), but major bleeding incidence was higher among patients with ESRD (IRR 1.84; P < 0.01). Individual patient-level data from seven studies comprising 4745 patients (268 with ESRD) were obtained and analysed. Similarly, there was no significant association between ESRD and stroke/TIA incidence (HR, 1.22; 95% CI, 0.66–2.26), but major bleeding was higher on patients with ESRD (HR, 1.65; 95% CI, 1.01–2.69).

Conclusion

LAAO represents a feasible option for thromboembolic prevention in patients with ESRD, although these patients have an increased risk of complications and bleeding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageAtrial FibrillationKidney Failure, ChronicThromboembolismStrokeCardiac CatheterizationHumansRisk FactorsTreatment OutcomeMaleFemaleAgedHemorrhageMiddle AgedIncidenceTime Factors

Stichwörter der Autor:innen

Atrial fibrillationLeft atrial appendage occlusionStroke

Autor:innen und Institutionen

  • Division of Cardiovascular Diseases, Mayo Clinic, 5777 East Mayo Boulevard, Phoenix, AZ 85054, USA.
  • Department of Invasive Cardiology and Electrophysiology, Deputy Director of the First Department of Medicine, Head of Cardiovascular Research, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg Uni…
  • Department of Invasive Cardiology, Hospital Universitario Mayor, Mederi, Bogotá, Colombia.
  • Texas Cardiac Arrhythmia Institute, St.David's Medical Center, Austin, TX, USA.
  • Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Network Guard-Heart, Jette, Brussels, Belgium.
  • Department of Cardiology, Angiology and Intensive Care Medicine-Division of Electrophysiology, University Heart Center Lübeck, Lübeck, Germany.

ORCID-Profile: Juan F Rodriguez-Riascos, Hema S Vemulapalli, Ibrahim Akin, Luis A Areiza, Domenico G Della Rocca, Ingo Eitel, Thomas Fink, Simonetta Genovesi, Joelle Kefer, David Zweiker, Poojan Prajapati, Komandoor Srivathsan

Förderung

  • Mayo Clinic Arizona Cardiovascular Clinical Research Center

Zitieren

APA

Rodriguez-Riascos, J. F., Vemulapalli, H. S., Akin, I., Areiza, L. A., Della Rocca, D. G., Eitel, I., Fink, T., Genovesi, S., Kefer, J., Zweiker, D., Prajapati, P., & Srivathsan, K. (2025). Left atrial appendage occlusion in patients with end-stage renal disease: an individual patient-level meta-analysis. Europace, 27(10). https://doi.org/10.1093/europace/euaf198

Vancouver

Rodriguez-Riascos JF, Vemulapalli HS, Akin I, Areiza LA, Della Rocca DG, Eitel I, et al. Left atrial appendage occlusion in patients with end-stage renal disease: an individual patient-level meta-analysis. Europace. 2025;27(10). doi:10.1093/europace/euaf198

BibTeX
@article{RodriguezRiascos2025,
  author = {Rodriguez-Riascos, Juan F and Vemulapalli, Hema S and Akin, Ibrahim and Areiza, Luis A and Della Rocca, Domenico G and Eitel, Ingo and Fink, Thomas and Genovesi, Simonetta and Kefer, Joelle and Zweiker, David and Prajapati, Poojan and Srivathsan, Komandoor},
  title = {Left atrial appendage occlusion in patients with end-stage renal disease: an individual patient-level meta-analysis},
  journal = {Europace},
  year = {2025},
  volume = {27},
  number = {10},
  doi = {10.1093/europace/euaf198}
}
Kostenlos starten →